Early Malignant Progression of Hereditary Medullary Thyroid Cancer (Q30320549)

17 June 2017

title

Early malignant progression of hereditary medullary thyroid cancer (English)

1 reference

https://api.crossref.org/works/10.1056/NEJMOA012915

17 June 2017

Early Malignant Progression of Hereditary Medullary Thyroid Cancer (English)

1 reference

21 March 2024

1 reference

11

Henning Dralle

1 reference

17 June 2017

Andreas Machens

1

1 reference

17 June 2017

Patricia Niccoli-Sire

2

1 reference

17 June 2017

Josef Hoegel

3

1 reference

17 June 2017

Karin Frank-Raue

4

1 reference

17 June 2017

Hans-Dietrich Roeher

6

1 reference

17 June 2017

Peter Lamesch

8

1 reference

17 June 2017

Friedhelm Raue

9

1 reference

17 June 2017

Bernard Conte-Devolx

10

1 reference

17 June 2017

European Multiple Endocrine Neoplasia (EUROMEN) Study Group

12

1 reference

17 June 2017

Theo J. van Vroonhoven

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14561794

reference URL

21 March 2024

Robert A. Wahl

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14561794

reference URL

21 March 2024

language of work or name

English

0 references

publication date

1 October 2003

1 reference

17 June 2017

16 October 2003

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=14561794

reference URL

full work available at URL

21 March 2024

http://www.nejm.org/doi/pdf/10.1056/NEJMoa012915

1 reference

https://api.crossref.org/works/10.1056/NEJMOA012915

The New England Journal of Medicine

21 March 2024

published in

1 reference

17 June 2017

volume

349

1 reference

17 June 2017

issue

16

1 reference

17 June 2017

page(s)

1517-1525

1 reference

Activation of a novel human transforming gene, ret, by DNA rearrangement

17 June 2017

cites work

https://api.crossref.org/works/10.1056/NEJMOA012915

1

1 reference

Mutations in the RET proto-oncogene are associated with MEN 2A and FMTC.

21 March 2024

https://api.crossref.org/works/10.1056/NEJMOA012915

2

1 reference

Germ-line mutations of the RET proto-oncogene in multiple endocrine neoplasia type 2A.

21 March 2024

https://api.crossref.org/works/10.1056/NEJMOA012915

3

1 reference

Seminars in medicine of the Beth Israel Hospital, Boston. The RET proto-oncogene in multiple endocrine neoplasia type 2 and Hirschsprung's disease

21 March 2024

https://api.crossref.org/works/10.1056/NEJMOA012915

4

1 reference

Dual effect on the RET receptor of MEN 2 mutations affecting specific extracytoplasmic cysteines

21 March 2024

https://api.crossref.org/works/10.1056/NEJMOA012915

5

1 reference

Guidelines for diagnosis and therapy of MEN type 1 and type 2.

21 March 2024

https://api.crossref.org/works/10.1056/NEJMOA012915

6

1 reference

Development of medullary thyroid carcinoma in transgenic mice expressing the RET protooncogene altered by a multiple endocrine neoplasia type 2A mutation

21 March 2024

https://api.crossref.org/works/10.1056/NEJMOA012915

7

1 reference

Multiple endocrine neoplasia type 2B mutation in human RET oncogene induces medullary thyroid carcinoma in transgenic mice

21 March 2024

https://api.crossref.org/works/10.1056/NEJMOA012915

8

1 reference

C-cell hyperplasia, pheochromocytoma and sympathoadrenal malformation in a mouse model of multiple endocrine neoplasia type 2B

21 March 2024

https://api.crossref.org/works/10.1056/NEJMOA012915

10

1 reference

Familial medullary thyroid carcinoma with noncysteine ret mutations: phenotype-genotype relationship in a large series of patients

21 March 2024

https://api.crossref.org/works/10.1056/NEJMOA012915

12

1 reference

Clinical screening as compared with DNA analysis in families with multiple endocrine neoplasia type 2A

21 March 2024

https://api.crossref.org/works/10.1056/NEJMOA012915

13

1 reference

Predictive DNA testing and prophylactic thyroidectomy in patients at risk for multiple endocrine neoplasia type 2A

21 March 2024

https://api.crossref.org/works/10.1056/NEJMOA012915

14

1 reference

Predictive DNA testing for multiple endocrine neoplasia 2: a therapeutic challenge of prophylactic thyroidectomy in very young children

21 March 2024

https://api.crossref.org/works/10.1056/NEJMOA012915

19

1 reference

Very early detection of RET proto-oncogene mutation is crucial for preventive thyroidectomy in multiple endocrine neoplasia type 2 children: presence of C-cell malignant disease in asymptomatic carriers

21 March 2024

https://api.crossref.org/works/10.1056/NEJMOA012915

20

1 reference

Ret-proto-oncogene analysis in medullary thyroid carcinoma

21 March 2024

https://api.crossref.org/works/10.1056/NEJMOA012915

21

1 reference

Is thyroidectomy necessary in RET mutations carriers of the familial medullary thyroid carcinoma syndrome?

21 March 2024

https://api.crossref.org/works/10.1056/NEJMOA012915

22

1 reference

Total thyroidectomy for hereditary medullary thyroid carcinoma 12 years after correction of Hirschsprung's disease

21 March 2024

https://api.crossref.org/works/10.1056/NEJMOA012915

23

1 reference

Novel germline RET proto-oncogene mutations associated with medullary thyroid carcinoma (MTC): mutation analysis in Japanese patients with MTC

21 March 2024

https://api.crossref.org/works/10.1056/NEJMOA012915

25

1 reference

Update on the MEN 2A c804 RET mutation: is prophylactic thyroidectomy indicated?

21 March 2024

https://api.crossref.org/works/10.1056/NEJMOA012915

27

1 reference

Multiple endocrine neoplasia 2A syndrome: Surgical management

21 March 2024

https://api.crossref.org/works/10.1056/NEJMOA012915

28

1 reference

Detection of medullary thyroid cancer by calcitonin assay in families

21 March 2024

https://api.crossref.org/works/10.1056/NEJMOA012915

31

1 reference

C-Cell Hyperplasia Preceding Medullary Thyroid Carcinoma

21 March 2024

https://api.crossref.org/works/10.1056/NEJMOA012915

32

1 reference

Inherited medullary microcarcinoma of the thyroid: a study of 11 cases

21 March 2024

https://api.crossref.org/works/10.1056/NEJMOA012915

33

1 reference

Germline RET 634 mutation positive MEN 2A-related C-cell hyperplasias have genetic features consistent with intraepithelial neoplasia

21 March 2024

https://api.crossref.org/works/10.1056/NEJMOA012915

34

1 reference

Prophylactic thyroidectomy in 75 children and adolescents with hereditary medullary thyroid carcinoma: German and Austrian experience.

21 March 2024

https://api.crossref.org/works/10.1056/NEJMOA012915

35

1 reference

Variable expressivity of familial medullary thyroid carcinoma (FMTC) due to a RET V804M (GTG-->ATG) mutation

21 March 2024

https://api.crossref.org/works/10.1056/NEJMOA012915

40

1 reference

21 March 2024

Identifiers

DOI

10.1056/NEJMOA012915

1 reference

17 June 2017

1 reference